O Odonate Therapeutics Inc
O
Fermé
0
Résumé
Variation du prix de l'action
24h
Min
Max
Odonate Therapeutics Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Odonate Therapeutics Inc
Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
